Connection

Maria Re to Cohort Studies

Back to Details
This is a "connection" page, showing publications Maria Re has written about Cohort Studies.
Maria Re
Connection Strength
0.029
Cohort Studies
  1. Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection. Int J Antimicrob Agents. 2004 Feb; 23(2):164-8.
    View in: PubMed
    Score: 0.013
  2. Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy. Infect Dis (Lond). 2018 05; 50(5):352-360.
    View in: PubMed
    Score: 0.008
  3. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.